Calcimedica Inc Quick Ratio (CALC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Calcimedica Inc   (NASDAQ: CALC)

Calcimedica Inc 's Quick Ratio

CALC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Calcimedica Inc 's Cash & cash equivalent grew by 127.83 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Calcimedica Inc 's Quick Ratio to 4.71, Quick Ratio remained below Calcimedica Inc average.

Within Major Pharmaceutical Preparations industry 189 other companies have achieved higher Quick Ratio than Calcimedica Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 627 to 1034.

Explain Quick Ratio?
How much Cash & cash equivalents CALC´s has?
What are CALC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CALC Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 40.73 % -27.31 % -49.34 % -19.45 % -9.01 %
Y / Y Cash & cash equivalent Change 3.58 % -66.85 % -30.28 % -3.55 % -6.17 %
Quick Ratio MRQ 4.71 3.48 8.97 6.53 6.4
CALC's Total Ranking # 1034 # 627 # 728 # 749 # 684
Seq. Current Liabilities Change 68.31 % 61.75 % -32.76 % -23.12 % -13.07 %
Seq. Cash & cash equivalent Change 127.83 % -37.28 % -7.58 % -21.57 % -27.08 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 190
Healthcare Sector # 318
Overall Market # 840


Quick Ratio Statistics
High Average Low
17.77 8.11 0.1
(Jun 30 2021)   (Dec 31 2022)




Financial Statements
Calcimedica Inc 's Current Liabilities $ 4 Millions Visit CALC's Balance sheet
Calcimedica Inc 's Cash & cash equivalent $ 19 Millions Visit CALC's Balance sheet
Source of CALC's Sales Visit CALC's Sales by Geography


Cumulative Calcimedica Inc 's Quick Ratio

CALC's Quick Ratio for the trailling 12 Months

CALC Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -14.45 % -26.09 % -19.05 % -51.96 % -50.02 %
Y / Y Cash & cash equivalent TTM Growth -28.99 % -30.91 % -10.8 % 6.57 % 7.33 %
Quick Ratio TTM 5.44 6.07 7.22 6.81 6.55
Total Ranking TTM # 777 # 749 # 569 # 540 # 573
Seq. Current Liabilities TTM Growth 13.05 % -9.14 % -12.78 % -4.5 % -2.34 %
Seq. Cash & cash equivalent TTM Growth 1.21 % -23.62 % -7.5 % -0.68 % -1.53 %

Quick ratio ranking by company, industry and sector >> Back to CALC Financial Strength Comparisons >> Go to Compare CALC Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q2 2026 to $3.95 millions, cumulative Quick Ratio decreased to 5.44 above the CALC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 429 other companies have achieved higher Quick Ratio than Calcimedica Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2640.

Explain Quick Ratio?
How much Cash & cash equivalents CALC´s has?
What are CALC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 430
Healthcare Sector # 874
Within the Market # 1034


trailing twelve months Quick Ratio Statistics
High Average Low
5.84 2.54 1.65
(Jun 30 2021)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Korro Bio Inc   12.89 $ 162.805  Millions$ 12.628  Millions
Atea Pharmaceuticals Inc   12.89 $ 362.382  Millions$ 28.124  Millions
Oric Pharmaceuticals Inc   12.76 $ 264.761  Millions$ 20.756  Millions
Diamedica Therapeutics Inc   12.42 $ 81.875  Millions$ 6.594  Millions
Vtv Therapeutics Inc   12.35 $ 86.643  Millions$ 7.017  Millions
Theravance Biopharma inc   12.30 $ 378.546  Millions$ 30.766  Millions
Coya Therapeutics Inc   12.29 $ 43.181  Millions$ 3.512  Millions
Bridgebio Oncology Therapeutics Inc   12.28 $ 634.167  Millions$ 51.634  Millions
Ocular Therapeutix Inc   12.17 $ 598.641  Millions$ 49.174  Millions
Wave Life Sciences Ltd   12.07 $ 613.194  Millions$ 50.815  Millions
Amylyx Pharmaceuticals Inc   11.86 $ 250.760  Millions$ 21.150  Millions
Moonlake Immunotherapeutics  11.83 $ 537.000  Millions$ 45.392  Millions
Eledon Pharmaceuticals Inc   11.77 $ 170.753  Millions$ 14.503  Millions
Tyra Biosciences Inc   11.76 $ 354.060  Millions$ 30.106  Millions
Opus Genetics Inc   11.69 $ 88.912  Millions$ 7.605  Millions
Aardvark Therapeutics Inc   11.57 $ 73.921  Millions$ 6.387  Millions
Dyne Therapeutics Inc   11.51 $ 898.475  Millions$ 78.029  Millions
Evommune Inc   11.50 $ 201.014  Millions$ 17.487  Millions
Bicara Therapeutics Inc   11.44 $ 497.259  Millions$ 43.475  Millions
Lipocine Inc   11.25 $ 23.267  Millions$ 2.068  Millions
Xenon Pharmaceuticals Inc   10.85 $ 930.686  Millions$ 85.795  Millions
Bicycle Therapeutics Plc  10.71 $ 510.052  Millions$ 47.635  Millions
Entrada Therapeutics Inc   10.44 $ 223.112  Millions$ 21.371  Millions
Vera Therapeutics Inc   10.33 $ 499.161  Millions$ 48.321  Millions
Ideaya Biosciences Inc   10.03 $ 828.955  Millions$ 82.677  Millions
Gri Bio Inc   9.95 $ 10.947  Millions$ 1.100  Millions
Renovorx Inc   9.86 $ 18.579  Millions$ 1.884  Millions
Savara Inc   9.83 $ 173.034  Millions$ 17.599  Millions
Bullfrog Ai Holdings Inc   9.79 $ 6.918  Millions$ 0.707  Millions
Enveric Biosciences Inc   9.63 $ 8.296  Millions$ 0.861  Millions

Date modified: 2026-09-26T07:38:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.